Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bastert

Showing results (271-280 of 291) with videos related to

Pageof 30
Sort By:
Journal of the National Cancer Institute|November 20, 1996
Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal statusI J Diel, M Kaufmann, S D Costa, et al.
International Journal of Cancer|April 13, 2000
Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients. The German Breast-Cancer Study GroupC Schmoor, G Bastert, J Dunst, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascitesU Räth, M Kaufmann, H Schmid, et al.
Cancer Research|April 28, 2001
Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodiesJ Schuhmacher, S Kaul, G Klivényi, et al.
Cancer Research|May 1, 1996
Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancerU Hamann, C Herbold, S Costa, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 1999
Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancerJ Huober, A Schneeweiss, S Hohaus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancerT Ahlert, W Sauerbrei, G Bastert, et al.
Geburtshilfe Und Frauenheilkunde|October 1, 1984
[Pregnancy and birth of monozygous female twins following in vitro fertilization and embryo transfer]L Mettler, H H Riedel, M Grillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study GroupM Schumacher, G Bastert, H Bojar, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancerR Haas, H Schmid, U Hahn, et al.
Pageof 30

Showing results (271-280 of 291) with videos related to

Sort By:
Pageof 30
Journal of the National Cancer Institute|November 20, 1996
Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal statusI J Diel, M Kaufmann, S D Costa, et al.
International Journal of Cancer|April 13, 2000
Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients. The German Breast-Cancer Study GroupC Schmoor, G Bastert, J Dunst, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascitesU Räth, M Kaufmann, H Schmid, et al.
Cancer Research|April 28, 2001
Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodiesJ Schuhmacher, S Kaul, G Klivényi, et al.
Cancer Research|May 1, 1996
Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancerU Hamann, C Herbold, S Costa, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 1999
Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancerJ Huober, A Schneeweiss, S Hohaus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancerT Ahlert, W Sauerbrei, G Bastert, et al.
Geburtshilfe Und Frauenheilkunde|October 1, 1984
[Pregnancy and birth of monozygous female twins following in vitro fertilization and embryo transfer]L Mettler, H H Riedel, M Grillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study GroupM Schumacher, G Bastert, H Bojar, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancerR Haas, H Schmid, U Hahn, et al.
Pageof 30